Amicus Therapeutics’ Galafold (migalastat) is the first oral treatment for the disease, and represents a rival to established enzyme replacement therapies (ERT), namely Genzyme’s Fabrazyme and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback